Pharmaceutical Technology Europe-10-01-2012

Pharmaceutical Technology Europe

Key considerations for outsourcing energy services.

Pharmaceutical Technology Europe
Ingredients

October 01, 2012

The physical form of an API is an important consideration in formulation development. Particle-engineering technologies, such as crystal design for controlling crystallisation and producing cocrystals, particle-size reduction and amorphous solid dispersions, help to optimise delivery of a drug.

Pharmaceutical Technology Europe

EMA has been increasing its interactions with other regulatory agencies across the globe. The agency's most talked about collaboration is with FDA, but EMA has also been intently focused on bolstering its relationship with its counterparts in Japan, India and Russia.

Issue PDF
Pharmaceutical Technology Europe

October 01, 2012

Click the title above to open the Pharmaceutical Technology Europe October 2012 issue in an interactive PDF format.